Stealth BioTherapeutics Corp (MITO:NASDAQ) soared at $0.27, representing a gain of 26.8%. On Fri, May 27, 2022, MITO:NASDAQ hit a New 2-Week Intraday Low of $0.2. The stock got featured on our News Catalysts scanner on Tue, May 31, 2022 at 09:41 AM in the 'BIOTECH' category. From Fri, May 13, 2022, the stock recorded 20.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Mar 23, 2022 at $0.79 with a volume of 2M+.
About Stealth BioTherapeutics Corp (MITO:NASDAQ)
Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.
Top 10 Gainers:
- TherapeuticsMD, Inc. (TXMD:NASDAQ), 364.02%
- JanOne Inc. (JAN:NASDAQ), 66.52%
- Mullen Automotive Inc. (MULN:NASDAQ), 44.9%
- Studio City International Holdings Limited (MSC:NYSE), 43.26%
- Xcel Brands, Inc. (XELB:NASDAQ), 36.7%
- DURECT Corporation (DRRX:NASDAQ), 32.08%
- Houston American Energy Corp. (HUSA:NYSEMKT), 27.39%
- Stealth BioTherapeutics Corp (MITO:NASDAQ), 26.83%
- mCloud Technologies Corp. (MCLD:NASDAQ), 25.67%
- BlackSky Technology Inc. Class A (BKSY:NYSE), 24.81%